Nova Patents
PL2807183T3

Synthetic apelin mimetics for the treatment of heart failure

Abstract

This record has no abstract on file.

Term

6.3 yearsto projected expiry

Projected expiry 25 January 2033, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

94 members in 43 offices

This recordMember, by publication datePriority claim33 more offices are in the list below

Priority claims18

Priority claims
DocumentOfficeKindDate
201261591557United States of AmericaP
201261591557United States of AmericaP
201261717760United States of AmericaP
201261717760United States of AmericaP
201261731697United States of AmericaP
201261731697United States of AmericaP
13711953European Patent Office (EPO)A
2013050666International Bureau of the World Intellectual Property Organization (WIPO)W
2013050666International Bureau of the World Intellectual Property Organization (WIPO)W
137119533–––
201261591557P–––
201261717760P–––
201261731697P–––
EP20130711953–––
US201261591557P–––
US201261717760P–––
US201261731697P–––
WO2013IB50666–––

Members94

Family members, oldest first
DocumentOfficeKind
AU2006294953A1AustraliaA1
CA2623548A1CanadaA1
WO2007038152A2World Intellectual Property Organization (WIPO)A2
WO2007038152A3World Intellectual Property Organization (WIPO)A3
US2007169776A1United States of AmericaA1
EP1933910A2European Patent Office (EPO)A2
CN101296721AChinaA
JP2009508647AJapanA
US7677246B2United States of AmericaB2
US2010126506A1United States of AmericaA1
BRPI0616337A2BrazilA2
JP2012061355AJapanA
AU2006294953B2AustraliaB2
AU2012203574A1AustraliaA1
EP1933910A4European Patent Office (EPO)A4
JP5033803B2JapanB2
US8375945B2United States of AmericaB2
CN101296721BChinaB
CA2862240A1CanadaA1
US2013196899A1United States of AmericaA1
WO2013111110A2World Intellectual Property Organization (WIPO)A2
US2013206140A1United States of AmericaA1
TW201335190ATaiwan Province of ChinaA
UY34593AUruguayA
WO2013111110A3World Intellectual Property Organization (WIPO)A3
US8673848B2United States of AmericaB2
US2014142022A1United States of AmericaA1
CO7020879A2ColombiaA2
MX2014009085AMexicoA
SG11201404369PASingaporeA
AP2014007846A0African Regional Intellectual Property Organization (ARIPO)A0
AR089808A1ArgentinaA1
AU2013213265A1AustraliaA1
IL233792A0IsraelA0
AU2012203574B2AustraliaB2
KR20140117603ARepublic of KoreaA
PH12014501701A1PhilippinesA1
CL2014001994A1ChileA1
CR20140364ACosta RicaA
EP2807183A2European Patent Office (EPO)A2
CN104220452AChinaA
PE20142194A1PeruA1
EA201491433A1Eurasian Patent Organization (EAPO)A1
JP2015506370AJapanA
CU20140097A7CubaA7
US9067971B2United States of AmericaB2
HK1200470AHong Kong, ChinaA
HK1200470A1Hong Kong, ChinaA1
US2015252076A1United States of AmericaA1
GT201400166AGuatemalaA
NZ627772ANew ZealandA
ECSP14016014AEcuadorA
CA2623548CCanadaC
TN2014000318A1TunisiaA1
AU2013213265B2AustraliaB2
ZA201405400BSouth AfricaB
AU2013213265C1AustraliaC1
EP1933910B1European Patent Office (EPO)B1
TWI576356BTaiwan Province of ChinaB
US9656034B2United States of AmericaB2
BR112014018306A2BrazilA2
CU24266B1CubaB1
BR112014018306A8BrazilA8
US2017232221A1United States of AmericaA1
US2017232221A1United States of AmericaA1
EA027853B1Eurasian Patent Organization (EAPO)B1
MX351569BMexicoB
CN104220452BChinaB
BRPI0616337B1BrazilB1
UA116196C2UkraineC2
EP2807183B1European Patent Office (EPO)B1
JP2018048157AJapanA
JP6313222B2JapanB2
IL233792AIsraelA
IL233792BIsraelB
LT2807183TLithuaniaT
PT2807183TPortugalT
US9982017B2United States of AmericaB2
SI2807183T1SloveniaT1
ES2670832T3SpainT3
DK2807183T3DenmarkT3
TR2018007309T4TürkiyeT4
TR201807309T4TürkiyeT4
HRP20180806T1CroatiaT1
RS57200B1SerbiaB1
PL2807183T3This recordPolandT3
HUE039137T2HungaryT2
JO3380B1JordanB1
CY1120239T1CyprusT1
JP6595553B2JapanB2
MY172268AMalaysiaA
KR20200003229ARepublic of KoreaA
KR102068370B1Republic of KoreaB1
BRPI0616337B8BrazilB8